Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q1 2024 · 10-Q
Revenue$0.00$0.00no prior Q1 2023 on file Net Income-$3.27M-$3.27MN/M vs Q1 2023 EPS Diluted-$4.28-$4.28N/M vs Q1 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Operating Cash Flow-$1,075,778N/M ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end